Apogee Therapeutics Inc. APGE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Apogee Therapeutics Inc. is a clinical-stage biotechnology company developing differentiated biologics for inflammatory and immune diseases. It focuses on advancing novel antibody therapeutics targeting well-established biological drivers to address conditions with high unmet needs, including atopic dermatitis, chronic…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees261
TickerAPGE
Statistics
Market Cap$6.52B
Revenue (TTM)$0
Net Income-$255.8M
Net Margin—
EPS$-3.74
P/E-23.87
P/S—
P/B5.04
EV/EBITDA-17.52
ROE-28.5%
Dividend Yield—
Price$87.09
Data: Twelve Data · Revenue = mcap / P/S